Adial Pharmaceuticals, Inc. Workers' Compensation Liability, Current
Adial Pharmaceuticals, Inc. (ADIL) had Workers' Compensation Liability, Current of $1.46 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Payables and Accruals › Accrued Liabilities, Current
us-gaap:WorkersCompensationLiabilityCurrent · last filed 2026-08-14
- 2026-06-30: Workers' Compensation Liability, Current $1.46M.
- 2026-03-31: Workers' Compensation Liability, Current $837.51K.
- 2025-12-31: Workers' Compensation Liability, Current $660.00K; Workers' Compensation Liability, Current as first filed $660.31K.
- 2025-09-30: Workers' Compensation Liability, Current $513.17K.
| Period end | Workers' Compensation Liability, Current | Workers' Compensation Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.46M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $837.51K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $660.00K 10-Q · filed 2026-08-14 | $660.31K 10-K · filed 2026-03-05 |
| 2025-09-30 | $513.17K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $372.56K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $588.44K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $405.25K 10-K · filed 2026-03-05 | |
| 2024-09-30 | $413.56K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $273.58K 10-Q · filed 2024-08-13 | |
| 2023-12-31 | $421.37K 10-K · filed 2025-03-04 | |
| 2023-09-30 | $354.11K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $276.70K 10-Q/A · filed 2023-10-30 | |
| 2023-03-31 | $1.09M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $761.51K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $686.50K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $498.63K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $357.54K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $520.79K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $444.56K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $278.95K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $232.98K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $322.44K 10-K · filed 2022-03-28 | |
| 2020-09-30 | $182.48K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $149.84K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $111.77K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $263.91K 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |